118 related articles for article (PubMed ID: 15705478)
1. Heterologous papillomavirus virus-like particles and human papillomavirus virus-like particle immune complexes activate human Langerhans cells.
Fausch SC; Da Silva DM; Kast WM
Vaccine; 2005 Feb; 23(14):1720-9. PubMed ID: 15705478
[TBL] [Abstract][Full Text] [Related]
2. Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells.
Yan M; Peng J; Jabbar IA; Liu X; Filgueira L; Frazer IH; Thomas R
Virology; 2004 Jul; 324(2):297-310. PubMed ID: 15207617
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.
Liu XS; Abdul-Jabbar I; Qi YM; Frazer IH; Zhou J
Virology; 1998 Dec; 252(1):39-45. PubMed ID: 9875315
[TBL] [Abstract][Full Text] [Related]
4. Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine.
García-Piñeres AJ; Hildesheim A; Trivett M; Williams M; Wu L; Kewalramani VN; Pinto LA
Eur J Immunol; 2006 Feb; 36(2):437-45. PubMed ID: 16385626
[TBL] [Abstract][Full Text] [Related]
5. Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells.
Lenz P; Lowy DR; Schiller JT
Eur J Immunol; 2005 May; 35(5):1548-56. PubMed ID: 15832296
[TBL] [Abstract][Full Text] [Related]
6. Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells.
Fausch SC; Da Silva DM; Kast WM
Cancer Res; 2003 Jul; 63(13):3478-82. PubMed ID: 12839929
[TBL] [Abstract][Full Text] [Related]
7. Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines.
Da Silva DM; Pastrana DV; Schiller JT; Kast WM
Virology; 2001 Nov; 290(2):350-60. PubMed ID: 11883199
[TBL] [Abstract][Full Text] [Related]
8. [Immunogenicity study of HPV 6b virus-like particles].
Liu Y; Liu X; Frazer IH
Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):587-9. PubMed ID: 12133476
[TBL] [Abstract][Full Text] [Related]
9. Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV/cottontail rabbit papillomavirus chimeric papillomavirus particles.
Mejia AF; Culp TD; Cladel NM; Balogh KK; Budgeon LR; Buck CB; Christensen ND
J Virol; 2006 Dec; 80(24):12393-7. PubMed ID: 17005666
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid dendritic cells are present in cervical carcinoma and become activated by human papillomavirus type 16 virus-like particles.
Bontkes HJ; Ruizendaal JJ; Kramer D; Meijer CJ; Hooijberg E
Gynecol Oncol; 2005 Mar; 96(3):897-901. PubMed ID: 15721448
[TBL] [Abstract][Full Text] [Related]
11. Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcgamma receptors and contributes to acquisition of T cell immunity.
Da Silva DM; Fausch SC; Verbeek JS; Kast WM
J Immunol; 2007 Jun; 178(12):7587-97. PubMed ID: 17548594
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus.
Istrate C; Douagi I; Charpilienne A; McInerney GM; Hidmark A; Johansen K; Larsson M; Magnusson KE; Poncet D; Svensson L; Hinkula J
Scand J Immunol; 2007 Jun; 65(6):494-502. PubMed ID: 17523941
[TBL] [Abstract][Full Text] [Related]
13. Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants.
Revaz V; Zurbriggen R; Moser C; Schiller JT; Ponci F; Bobst M; Nardelli-Haefliger D
Antiviral Res; 2007 Oct; 76(1):75-85. PubMed ID: 17617476
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses.
Fausch SC; Da Silva DM; Rudolf MP; Kast WM
J Immunol; 2002 Sep; 169(6):3242-9. PubMed ID: 12218143
[TBL] [Abstract][Full Text] [Related]
15. Transcutaneous vaccination with virus-like particles.
Young SL; Wilson M; Wilson S; Beagley KW; Ward V; Baird MA
Vaccine; 2006 Jun; 24(26):5406-12. PubMed ID: 16621190
[TBL] [Abstract][Full Text] [Related]
16. Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation.
de Witte L; Zoughlami Y; Aengeneyndt B; David G; van Kooyk Y; Gissmann L; Geijtenbeek TB
Immunobiology; 2007; 212(9-10):679-91. PubMed ID: 18086370
[TBL] [Abstract][Full Text] [Related]
17. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.
Olsson SE; Villa LL; Costa RL; Petta CA; Andrade RP; Malm C; Iversen OE; Høye J; Steinwall M; Riis-Johannessen G; Andersson-Ellstrom A; Elfgren K; von Krogh G; Lehtinen M; Paavonen J; Tamms GM; Giacoletti K; Lupinacci L; Esser MT; Vuocolo SC; Saah AJ; Barr E
Vaccine; 2007 Jun; 25(26):4931-9. PubMed ID: 17499406
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation.
Fausch SC; Fahey LM; Da Silva DM; Kast WM
J Immunol; 2005 Jun; 174(11):7172-8. PubMed ID: 15905561
[TBL] [Abstract][Full Text] [Related]
19. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
Bessa J; Schmitz N; Hinton HJ; Schwarz K; Jegerlehner A; Bachmann MF
Eur J Immunol; 2008 Jan; 38(1):114-26. PubMed ID: 18081037
[TBL] [Abstract][Full Text] [Related]
20. Immunobiology of HPV and HPV vaccines.
Stanley M
Gynecol Oncol; 2008 May; 109(2 Suppl):S15-21. PubMed ID: 18474288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
